Company intelligence / Profile preview

Zeta I

Lieboch, Styria, Austriazetaglobal.com ↗

Ownership: Private
Employees: ~1400
Development stage: Commercial

Overview

The ZETA Group is a global end-to-end solution provider specializing in designing, constructing, automating, digitalizing, and qualifying customer-specific biopharmaceutical systems for aseptic process solutions. They support pharma/biotech companies from lab-scale development through industrial-scale manufacturing and market introduction. Their expertise includes plant engineering for monoclonal antibodies, vaccines, cell/gene therapies; digitalization ("Pharma 4.0"); decarbonization strategies; single-use technologies; cleanroom/HVAC design; automation; qualification services.

Modalities: Monoclonal antibodyAntibody-drug conjugateVaccinePeptidesCell therapyGene therapy
Industry: Contract Manufacturing Organization

Partnerships

Works with leading global pharmaceutical and biotech companies on facility projects

Beyond the preview

Go deeper on Zeta I.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zeta I.

Explore the full profile